Management and Treatment of Ductal Carcinoma in Situ (DCIS)

Join Dr. Swati Kulkarni, FACS, Breast Surgery, Northwestern Medicine, and Professor of Surgery, Northwestern University, Feinberg School of Medicine, to learn about the management and treatment of Ductal Carcinoma in Situ (DCIS)—the presence of abnormal cells inside a milk duct in the breast. DCIS is considered the earliest form of breast cancer. DCIS is noninvasive, meaning it hasn't spread outside of the milk duct. While DCIS isn't an emergency, it does require an evaluation and a consideration of treatment options. According the American Cancer Society, "About 1 in 5 new breast cancers will be ductal carcinoma in situ (DCIS). Nearly all women with this early stage of breast cancer can be cured." ► For more information about "The Promise Study" for women with newly diagnosed Ductal Carcinoma in Situ (DCIS), which was mentioned by Dr. Kulkarni, visit Facebook.com/ThePromiseStudy. ► For a helpful visual of DCIS and IDC that corresponds with Dr. Kulkarni's presentation, visit http://bit.ly/LW_DCIS. ► Follow us on http://Facebook.com/livingwellcrc and http://livingwellcrc.org to keep up to date on all LivingWell online programming.